Global Specific Antiviral Drugs for Covid-19 Market Size, Share, Growth, Industry Trends and Forecast 2020-2030

Global specific antiviral drugs for covid-19 market size accounted to USD XXX in 2020 and is expected to reach USD XXX by 2030 growing with a CAGR of XXX during the forecast period.Covid-19 being considered the deadliest virus in the history of mankind, owing to which all national and international agencies and government bodies are taking necessary actions to curb the spread of this pandemic. The disease has no known approved vaccine yet and the reason being few identified antiviral medicines are under scrutiny and clinical trials to find if they can be used for the treatment of Covid-19 disease. Recently Food and Drug Administration (FDA) has given approval to 3 medicines as emergency use authorization (EUA) which allows the doctors to use them for the treatment of Covid-19. The medicines are chloroquine and hydroxychloroquine, which are known as anti-malaria drugs and remdesivir, which is an antiviral drug. Remdesivir is a popularly known drug which has shown good responses in some of the clinical trial during Covid-19 medication and is among the most used drug after hydroxychloroquine. Some of the other known medicines in use are Kaletra, Favipiravir, Arbidol, and Monoclonal Antibodies. Gilead Sciences Inc is the manufacturer of remdesivir and has given licensees to other big pharmaceutical companies like Mylan, Cipla, Hetero Labs and Jubilant Life Sciences in India, as well as Ferozsons Laboratories in Pakistan in order to manufacture the drug on a large scale and distribute remdesivir in 127 countries.
Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020254
Market Dynamics and Factors:
Remdesivir was once got failed during the clinical trials for the treatment of MERS (Middle East Respiratory Syndrome) in 2014, however, this drug proved to be effective for the treatment of Covid-19 and therefore the requirement for the drug has grown in the market. However, other alternatives like Kaletra, Favipiravir, Arbidol, and Monoclonal Antibodies are available, and this will restrain specific antiviral drugs for covid-19 market growth. Remdesivir, moreover is currently the only known drug for the treatment of Covid-19 and has emerged as a major market player and will show good growth in the future. However, the side effect of the drug in the patients having heart and diabetes diseases will be a constraint for the specific antiviral drugs for covid-19 market growth.
Market Segmentation:
Global Specific Antiviral Drugs for COVID-19 Market– By Drug Type
Remdesivir
Hydroxychloroquine & chloroquine
Kaletra
Favipiravir
Arbidol, and
Monoclonal antibodies
Global Specific Antiviral Drugs for COVID-19 Market – By Application
Covid-19, and
Other viral diseases
Global Specific Antiviral Drugs for COVID-19 Market – By Mechanism Of ActionReverse transcriptase inhibitors
Nucleotide polymerase inhibitors
Protease inhibitors, and
Others
Global Specific Antiviral Drugs for COVID-19 Market– By End User
Hospitals
Clinics, and
Others

Global Specific Antiviral Drugs for COVID-19 Market– By Region
North America
U.S.
Canada
Mexico
Europe
UK.
France
Germany
Italy
Rest of Europe

Asia-Pacific
Japan
China
India
Australia
Rest of Asia-Pacific

RoW
Latin America
Middle East
Africa
New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020254
Geographic Scenario:
According to the report of Institute for Clinical and Economic Review (ICER), U.S. states that if the price of drug remdesivir needs to be fixed on the basis of cost then considering the duration of treatment, it is assumed that the course will be of 10 days and as per the price can be fixed as USD 10. Whereas, on the basis of the effectiveness of the drug it is assumed that the price may range to USD 4,500, and if the drug is being used to only shorten the duration of stay in the hospital then it is assumed that the price will vary to USD 390. North America, is considered to be the largest in specific antiviral drugs for covid-19 market for the drug due to the high number of Covid-19 patients as on May 2020. The market revenue for remdesivir is expected to be USD 1 billion by 2021 and the growth rate is estimated to grow more than by a CAGR of 10% in 2021.
Competitive Scenario:
The key players in the specific antiviral drugs for covid-19 industry are Bristol-Myers Squibb Company, Gilead Sciences, GlaxoSmithKline plc., AbbVie Inc., Merck & Co., Inc., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche AG, Cipla Inc., Johnson & Johnson Services, Inc., and Aurobindo Pharma.
Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020254
How will this Market Intelligence Report Benefit You?
The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.
Exclusive insight into the key trends affecting the Global Specific Antiviral Drugs for Covid-19 industry, although key threats, opportunities and disruptive technologies that could shape the Global Specific Antiviral Drugs for Covid-19 Market supply and demand.
The report tracks the leading market players that will shape and impact the Global Specific Antiviral Drugs for Covid-19 Market most.
The data analysis present in the Global Specific Antiviral Drugs for Covid-19 Market report is based on the combination of both primary and secondary resources.
The report helps you to understand the real effects of key market drivers or retainers on Global Specific Antiviral Drugs for Covid-19 Market business.
The 2021 Annual Global Specific Antiviral Drugs for Covid-19 Market offers:
100+ charts exploring and analysing the Global Specific Antiviral Drugs for Covid-19 Market from critical angles including retail forecasts, consumer demand, production and more
15+ profiles of top producing states, with highlights of market conditions and retail trends
Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand
Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Specific Antiviral Drugs for Covid-19 Market type
Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020254
About Us:
Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.
Contact:
Email: [email protected]
For Latest Update Follow Us:
https://www.facebook.com/Decision-Foresight-110793387201935
https://twitter.com/DecisionFs
https://www.linkedin.com/company/decision-foresight/